Nasdaq

Interesting ACAD Put And Call Options For February 2022

Investors in Acadia Pharmaceuticals Inc (Symbol: ACAD) saw new options become available today, for the February 2022 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...
Seeking Alpha

ACADIA Pharmaceuticals Inc. (ACAD) Q4 2022 Earnings Call Transcript

Good day, ladies and gentlemen. And welcome to ACADIA Pharmaceuticals Fourth Quarter and Full Year 2022 Financial Results Conference Call. My name is Gigi, and I will be your coordinator for today. At ...
Seeking Alpha

ACADIA Pharmaceuticals, Inc. (ACAD) CEO Stephen Davis on Q2 2022 Results - Earnings Call Transcript

Good day, ladies and gentlemen, and welcome to the ACADIA Pharmaceuticals Second Quarter 2022 Financial Results Conference Call. [Operator Instructions]. Please be advised that today's conference is ...
The Globe and Mail

Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operating Overview

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), today announced its financial results for the fourth quarter and full year ended December 31, 2022. NUPLAZID ® delivered net sales of $136.5 million in the ...
Nasdaq

Interesting ACAD Put And Call Options For January 2022

Investors in Acadia Pharmaceuticals Inc (Symbol: ACAD) saw new options become available today, for the January 2022 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...